This young adult female presents complaining of progressive dyspnea on exertion and generalized weakness. She reports several days of nausea, vomiting, and diarrhea one week prior to onset of dyspnea.
This middle-aged, obese female was brought in by EMS following a syncopal event. She reported several days of malaise and progressive dyspnea but denied fevers or a cough. The physical exam was unremarkable. The patient was triaged as a rule-out COVID-19 patient due to recent travel to New York and complaints of malaise and dyspnea.
An important application of ultrasound in COVID-positive or rule-out COVID patients presenting with gastrointestinal symptoms is to identify alternative etiologies for these symptoms (e.g., small bowel obstruction).
Documented gastrointestinal manifestations in coronavirus disease 2019 (COVID-19) patients include anorexia, nausea, vomiting, abdominal pain, and diarrhea.
Bedside ultrasound appears to be a valuable method of rapidly assessing lung involvement and monitoring disease progression in patients with COVID-19 infections.
Evidence is rapidly emerging that COVID-19 patients may present with a myriad of cardiac complications, including acute myocardial injury, myocarditis, and dysrhythmias (Arentz et al., Clerkin et al., Huang et al.).
Bedside ultrasound may prove to be a sensitive early indicator of lung involvement in patients with coronavirus 2019 (COVID-19) infection.
In support of the evolving healthcare demands and increased need for remote learning, we are waiving the minimum five Module purchase requirement on our SonoSim Personal Solution.